TG Therapeutics Announces Positive Topline Results
Researchers at Queen’s University Belfast in the UK, are conducting the first large-scale survey of Monoclonal B-cell lymphocytosis patients and individuals with other precancerous conditions to investigate the impact of being diagnosed and living with a precancerous condition.
We are particularly interested to know more about how you feel about your Monoclonal B-cell lymphocytosis and the impact, if any, Monoclonal B-cell lymphocytosis has had on your life since diagnosis.
The findings of this study will be used to inform future healthcare service provision for individuals with precancers and will be published in a scientific peer reviewed journal.
To learn more about this study and to take part please click here: http://go.qub.ac.uk/QUBPIP1
All responses to the survey are anonymous (i.e. it will not be possible to identify you from any of the responses provided) and it should take no longer than 15-20 minutes to complete.
We look forward to hearing your opinions and appreciate your time and participation.
Thank you for helping to further our research.
Blain Murphy MSc MBPsS
PhD Researcher
Queens University Belfast
March 16, 2018
Related posts